Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
5,467,627
-
Shares change
-
+558,643
-
Total reported value, excl. options
-
$102,055,050
-
Value change
-
+$15,755,685
-
Number of buys
-
40
-
Number of sells
-
-17
-
Price
-
$18.67
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2019
64 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2019.
XBiotech Inc. - Common Shares, no par value (XBIT) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,467,627 shares
of 33,289,095 outstanding shares and own 16.42% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,751,921 shares), VANGUARD GROUP INC (989,302 shares), GEODE CAPITAL MANAGEMENT, LLC (336,479 shares), STATE STREET CORP (335,479 shares), Sofinnova Investments, Inc. (240,995 shares), NORTHERN TRUST CORP (231,091 shares), D. E. Shaw & Co., Inc. (175,789 shares), ClariVest Asset Management LLC (162,006 shares), MILLENNIUM MANAGEMENT LLC (138,557 shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (88,805 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.